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When the catalytic A subunits of the castor 
bean toxins ricin and Ricinus communis 
agglutinin (denoted as RTA and RCA A, 
respectively) are delivered into the 
endoplasmic reticulum (ER) of tobacco 
protoplasts, they become substrates for ER-
associated protein degradation (ERAD). As 
such, these orphan polypeptides are retro-
translocated to the cytosol, where a significant 
proportion of each protein is degraded by 
proteasomes. Here we begin to characterise 
the ERAD pathway in plant cells, showing 
that retro-translocation of these lysine-
deficient glycoproteins requires the ATPase 
activity of cytosolic CDC48. Lysine 
polyubiquitination is not obligatory for this 
step. We also show that while RCA A is found 
in a mannose-untrimmed form prior to its 
retro-translocation, a significant proportion of 
newly synthesised RTA cycles via the Golgi 
and becomes modified by downstream 
glycosylation enzymes. Despite these 
differences, both proteins are similarly retro-
translocated.  
 
As in mammalian and yeast cells, the plant cell 
endoplasmic reticulum3 (ER) is a major protein 
folding compartment. Newly synthesised soluble 
and membrane proteins destined to remain in the 
ER, or to be transported to the Golgi complex, 
vacuoles or apoplast, are scrutinized by a 
stringent quality control system (1). Such 
surveillance ensures that newly synthesized 
proteins assume their native conformation and, 
where appropriate, assemble into oligomers. In 
mammalian and yeast cells, proteins that fail to 
fold and/or assemble correctly are usually retro-
translocated to the cytosol and degraded by 
cytosolic proteasomes, in a tightly coupled 
pathway referred to as ER-associated protein 
degradation (ERAD) (2,3). For the majority of 
misfolded or unassembled substrates, extraction 
from the ER membrane requires a cytosolic 
ubiquitin-interacting AAA-ATPase complex 
designated CDC48 in yeast (p97, also known as 
valosin-containing protein, in mammalian cells), 
in association with the adaptor proteins Ufd1p 
and Npl4p (4-8). This complex is believed to use 
its ATPase activity to segregate ubiquitinated 
ERAD substrates (7,9), and/or mechanically 
extract them from the ER membrane in readiness 
for delivery to proteasomes (5,8). However, not 
all ERAD substrates are modified by ubiquitin 
and extracted by this ATPase (8,10-12), leading 
to the suggestion that an alternative driving force 
must exist. For pre-pro α-factor, this has been 
shown to be the ATPases located at the base of 
the 19S proteasome regulatory complex (10). 
 
A pathway closely resembling ERAD also 
operates in plant cells but, by comparison, 
relatively little is known about substrate 
recognition, extraction from the ER membrane, 
or the pathway(s) and machineries for 
degradation (13). The Arabidopsis thaliana 
genome contains sequences for three CDC48-like 
proteins, one of which has been functionally 
shown to complement a yeast CDC48 mutant 
(14,15). This AAA-ATPase has been found to 
play a role in the quality control of a mutant 
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polytopic membrane protein, barley (Hordeum 
vulgare) powdery mildew resistance protein 
(MLO), but its involvement in ERAD is thus far 
limited to this one example (16). The process of 
retro-translocation, deglycosylation and 
proteasomal degradation in plant cells was first 
characterized by studying the biosynthesis of the 
catalytic A subunit (RTA) of the A-B plant toxin 
ricin (17). This orphan polypeptide, once 
delivered into the ER by its signal peptide, was 
shown to retro-translocate in a manner unrelated 
to its propensity for ubiquitination (18). While it 
was shown that ubiquitination of internal lysine 
residues is not a strict requirement for ER-to-
cytosol transport of this protein, the involvement 
or otherwise of CDC48 was not investigated. 
Here we have studied the effects of a dominant 
negative form of Arabidopsis CDC48 on the 
export of the orphan catalytic polypeptides of 
ricin and its close relative, Ricinus communis 
agglutinin, in tobacco protoplasts. The data 
presented clearly demonstrate that the retro-
translocation of these proteins requires the 
participation of CDC48, and is irrespective of 
their glycosylation or ubiquitination status. 
 
EXPERIMENTAL PROCEDURES 
 
Recombinant DNA – All DNA constructs were 
generated in the CaMV 35S promoter-driven 
expression vectors pDHA ((19), for toxin- and 
phaseolin-based constructs) and pamPAT-MCS 
(GenBank accession number AY436765 (16)) or 
pGreenII-0029 ((20), for CDC48- or fluorescent 
protein-based constructs).  Expression constructs 
encoding RTA, phaseolin (pDHE-T343F), 
CDC48 and cytosolic YFP have been described 
previously (16,21-23). The ricin active site 
substitution E177D, the lysine substitutions K4R 
and K239R, and the removal of the proricin 
signal peptide and N-terminal propeptide have 
also been previously documented (18,24,25). All 
derivative constructs used in this work were 
generated using the QuickChange™ in vitro 
mutagenesis system (Stratagene, La Jolla, 
California, USA) using the following mutagenic 
primers (and their reverse complements, not 
shown): a stop codon was introduced into the 
preproRCA sequence (26) immediately after the 
open reading frame of the A chain to generate 
pRCA A using 5′-
CCTCCACCGTCGTCAGAGTTTTAGTTGCTT
ATAAGGCCAGTGGTGCC-3′, and the 
equivalent active site substitution E176D was 
introduced into pRCA A using 5′-
GGTTTGCATCCAAATGATTTCAGACGCAG
CAAGATTCCAGTACATTG-3′. Sites of amino 
acid mutations are underlined. wtCDC48 and 
CDC48QQ were cloned into the HindIII-SmaI 
sites of the CaMV 35S cassette using the primers 
5′-ATATATATAAGCTTATGTCTACCCCAGC 
TG-3′ and 5′-AACGAAGCCCGGGCTAATTGT 
AGAGATC-3′, for subsequent insertion into 
EcoRV-cut pGreenII-0029, used for tobacco leaf 
infiltration. Restriction enzyme sites are 
underlined. To generate cytosolic RFP, the 
monomeric RFP1 coding region was amplified 
by PCR from pcDNA1-mRFP (27) and cloned 
into the XbaI-SacI sites of the CaMV 35S 
cassette using the primers 5′- 
GCGCGCGTCTAGAATGGCCTCCTCCGAGG
AC-3′ and 5′- 
TAATGATGGAGCTCTTAGGCGCCGGTGGA
GTGGC-3′, again for subsequent insertion into 
EcoRV-cut pGreenII-0029. Restriction enzyme 
sites are underlined. 
 
Transient transfection of tobacco leaf protoplasts 
and pulse-chase experiments – Protoplasts were 
prepared from axenic leaves (4 to 7 cm long) of 
Nicotiana tabacum cv. Petit Havana SR1 (28), 
and were subjected to polyethylene glycol-
mediated transfection with one or more plasmids 
as previously described (22). Cells were 
radiolabeled with Pro-Mix (a mixture of [35S]-
cysteine and [35S]-methionine (GE Healthcare, 
Amersham, Buckinghamshire, UK)), and chased 
for the times indicated in the figures, as 
previously described (21). In some experiments, 
before radioactive labeling, protoplasts were 
incubated for 1 hour at 25°C in K3 medium 
(3.78g/l Gamborg's B5 basal medium with 
minimal organics, 750mg/l CaCl2.2H2O, 250mg/l 
NH4NO3, 136.2g/l sucrose, 250mg/l xylose, 
1mg/l 6-benzylaminopurine (6-BAP), 1mg/l α-
naphthalenacetic acid (NAA)) supplemented with 
either 50µg/ml tunicamycin (Sigma-Aldrich, 
Poole, Dorset, UK; 5mg/ml stock in 10mM 
NaOH) or 5mM 1-deoxymannojirimycin (Sigma-
Aldrich, Poole, Dorset, UK; 0.2M stock in sterile 
H2O). When indicated, clasto-lactacystin β-
lactone (Calbiochem, San Diego, California, 
USA; 20mM stock in dimethyl sulphoxide) was 
added to a concentration of 80µM at the 
beginning of the labeling period. At the desired 
time points, 3 volumes of cold W5 medium (9g/l 
NaCl, 0.37g/l KCl, 18.37g/l CaCl2.2H2O, 0.9g/l 
glucose) were added and protoplasts were 
pelleted by centrifugation at 60×g for 10 minutes 
at 4°C. Separated cell and media samples were 
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frozen on dry ice and stored at –80°C, unless 
further manipulations were to be performed as 
below. 
 
Tobacco leaf infiltration – The lower epidermis 
of 3 to 5 cm long tobacco leaves from a 3 to 4 
week old plant were pressure-infiltrated with a 
culture of Agrobacterium tumefaciens 
(transformed with empty vector, pGreenII-0029, 
or with either wild type or mutant CDC48) 
diluted to an OD600 of 0.1 in infiltration media 
(50mM MES pH 5.6, 0.5% (w/v) glucose, 2mM 
Na3PO4, 100µM acetosyringone (10mM stock in 
EtOH)). The plant was then incubated in 
greenhouse conditions for a further 3 days before 
preparation of protoplasts.
 
Protoplast fractionation – Protoplast pellets 
(from 500,000 cells) were resuspended in 140µl 
of 12% sucrose buffer (100mM Tris-HCl pH 7.6, 
10mM KCl, 1mM EDTA, 12% (w/w) sucrose, 
supplemented immediately before use with 
Complete™ protease inhibitor cocktail (Roche 
Applied Science, Mannheim, Germany)) and 
homogenized by pipetting 50 times with a 
Gilson-type micropipette through a 200µl tip. 
Intact cells and debris were removed by 
centrifugation at 500×g for 5 minutes at 4°C. 
130µl was loaded onto a 17% (w/w) sucrose pad 
and centrifuged at 100,000×g for 30 minutes at 
4°C. Pellets (microsomes) and supernatants 
(soluble proteins) were frozen on dry ice and 
stored at –80°C. 
 
Protease protection assay – Protoplast pellets 
(from 500,000 cells) were homogenized in 12% 
sucrose buffer as described above, this time 
omitting protease inhibitors, and cell debris was 
removed by centrifugation at 500×g for 5 minutes 
at 4°C. Supernatants were divided into three 
aliquots and incubated for 30 minutes at 25°C 
with either buffer (negative control) or proteinase 
K (5mg/ml stock in 50mM Tris-HCl pH 8.0, 
1mM CaCl2) at a final concentration of 75µg/ml 
in the presence or absence of 1% Triton X-100. 
Phenylmethylsulfonyl fluoride was added to a 
final concentration of 20mM to inhibit proteinase 
K before immunoprecipitation. Samples were 
frozen on dry ice and stored at –80°C. 
 
Preparation of protein extracts and 
immunoprecipitation – Frozen samples were 
homogenized by adding 2 volumes of cold 
protoplast homogenization buffer (150mM Tris-
HCl pH7.5, 150mM NaCl, 1.5mM EDTA, 1.5% 
(w/v) Triton X-100, supplemented immediately 
before use with Complete™ protease inhibitor 
cocktail). Homogenates were used for 
immunoprecipitation with polyclonal rabbit anti-
RTA, anti-BiP (22), anti-phaseolin (22), anti-
calreticulin (29) or anti-GRP94 (30) antisera. 
Immunoselected polypeptides were analysed by 
15% SDS-PAGE. Gels were fixed, treated with 
Amplify™ (GE Healthcare, Amersham, 
Buckinghamshire, UK), and radioactive 
polypeptides revealed by fluorography. Band 
intensity was determined using TotalLab 2003 
software (Non-linear Dynamics, Newcastle-
upon-Tyne, UK). 
 
Toxicity measurements – Triplicate aliquots of 
330,000 protoplasts were co-transfected with a 
toxin-encoding plasmid or empty vector (pDHA), 
a CDC48-encoding plasmid or empty vector 
(pamPAT-MCS), and the phaseolin-encoding 
plasmid (pDHE-T343F). After 16 hours of 
recovery, protoplasts were pulse-labeled for 1 
hour before being pelleted as described above. 
Polypeptides immunoselected from homogenates 
using anti-phaseolin antiserum were separated by 
SDS-PAGE, before fluorography and 
densitometry as before. Toxicity of the various 
constructs was expressed as a percentage of 
phaseolin synthesis with respect to protoplasts 
co-transfected with empty vector instead of toxin. 
 
Endoglycosidase H treatment – Protein A-
Sepharose beads carrying immunoprecipitated 
protein were resuspended in 20µl sodium citrate 
buffer (0.25M sodium citrate pH 5.5, 0.2% (w/v) 
SDS) and boiled for 5 minutes. Supernatants 
were treated with 10mU endoglycosidase H 
(Roche Applied Science, Mannheim, Germany; 
5mU/µl stock) at 37°C for 16 hours. 
 
Confocal microscopy – Transfected protoplasts 
were mounted in K3 and imaged with a Leica 
TCS SP5 confocal laser-scanning microscope, 
using a 40× oil immersion objective lens (NA 
1.25). YFP was excited at 514 nm and detected in 
the 525 to 583 nm range. RFP was excited at 561 
nm and detected in the 592 to 635 nm range. 
Simultaneous detection of YFP or RFP was 
performed by combining the settings indicated 
above in the sequential scanning facility of the 
microscope, as instructed by the manufacturer. 
 
Statistical analysis – Each experiment was 
repeated 3 or 4 times (see individual figures) and 
data groups were analysed using one-way 
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ANOVA. When a significant effect between 
sample groups was detected, the groups were 
compared using Tukey post-hoc tests. Statistical 
analysis was performed using SPSS v14.0. 
 
RESULTS 
 
Dominant negative CDC48QQ induces an up-
regulation of ER chaperones - We rationalized 
that the presence of a dominant negative CDC48 
would lead to the accumulation of aberrant 
proteins within the ER lumen as a prelude to an 
up-regulation of ER chaperones as part of the 
unfolded protein response (UPR). Such a 
phenotype would confirm the efficacy of the 
expressed CDC48 mutant. We therefore prepared 
protoplasts from sections of leaf tissue that had 
been subjected to Agrobacterium-mediated 
infiltration. The transformed protoplasts 
expressed either empty vector, wild type CDC48, 
or a mutant CDC48 in which the conserved 
glutamate residues of the Walker B motifs (E308 
and E581) of the two ATPase domains had been 
replaced by glutamine (denoted CDC48QQ) (16). 
After three days, the levels of BiP, calreticulin 
and GRP94 were increased in cells that were 
expressing CDC48QQ (Fig. 1A). The 
quantitation of these data is shown in Fig. 1B, 
where it can be seen that a statistically significant 
difference is observed in chaperone levels when 
CDC48QQ is expressed. It should be noted that 
the up-regulation observed is likely to be an 
underestimate since the agrobacterial infiltration 
method used in these experiments, although more 
efficient that other methods of plant cell 
transformation, is unlikely to be 100% efficient. 
ER chaperones will therefore not be induced in a 
proportion of the cells taken for analysis.  
 
Expression of dominant negative CDC48 
increases the stability of ER-sequestered RTA – 
We then followed the fate of ER-sequestered 
RTA in tobacco protoplasts 16 hours after PEG-
mediated co-transfection of plasmids encoding 
toxin together with either wild-type CDC48 or 
mutant CDC48, or in the presence of the  
glycosylation inhibitor (and UPR inducer) 
tunicamycin (31). To minimize inhibition of 
protein synthesis and thereby maximize the 
amount of newly made toxin that could be 
visualized, we used in these (and some of the 
subsequent) experiments a catalytic point mutant, 
RTAE177D, which has been shown to have 
virtually native structure (32) but a 70-fold 
reduced potency to ribosomes (24). As shown 
from the representative pulse-chase experiment in 
Fig. 2A, the glycosylated RTA made in a one 
hour pulse with radiolabeled cysteine and 
methionine was degraded with a half-life of 
approximately 3.5 hours in cells expressing wild-
type CDC48. In cells expressing CDC48QQ, the 
rate of RTA degradation was significantly and 
reproducibly reduced as shown by quantification 
and statistical analysis of bands taken from four 
independent repeats of this experiment (Fig. 2B). 
Although the expression of CDC48QQ was in 
itself toxic to cells, such that transfected cells 
synthesized only 40% as much RTA as cells 
expressing wild-type CDC48, the RTA that was 
made was more stable (Fig. 2), with a half-life of 
greater than 5 hours (data not shown). The 
slightly increased gel mobility of the A chain 
bands during the chase (Fig. 2A, lanes 6-8, 10-12) 
most likely represents the emergence of a 
mannose-trimmed species. Fig. 2B quantifies the 
kinetics of degradation averaged from four 
separate experiments. It is noticeable that, unlike 
CDC48QQ, tunicamycin treatment to block 
glycosylation and to promote a generalised UPR, 
does not impede the disappearance of RTA (Fig. 
2A, lanes 13-16). 
 
Expression of mutant CDC48 hampers the retro-
translocation of toxin subunits – We have 
previously shown that a proportion of retro-
translocated RTA uncouples from the 
degradation pathway and refolds to inactivate 
ribosomes (18). A reduction in the protein 
biosynthetic capacity of these cells is therefore 
indicative of retro-translocation activity. To 
monitor protein synthesis in the transfected cell 
population alone we quantified, in triplicate, the 
levels of a reporter protein (phaseolin) encoded 
by a plasmid that was co-transfected (in a triple 
transfection) into protoplasts along with a 
plasmid encoding either a cytosolic RTA (cRTA), 
an ER-targeted RTA (RTA), or the non 
recombinant vector pDHA (no toxin) together 
with one of the CDC48 constructs (or vector 
alone (pamPAT-MCS)). Following overnight 
expression and a one hour pulse with 
radiolabeled cysteine and methionine, the 
triplicate phaseolin immunoprecipitates were 
quantified from gels. As shown in Fig. 3A, 
protein synthesis in cells making ER-targeted 
RTA (with and without the wild-type CDC48 
construct) is reduced by ~60%. In contrast, 
protein synthesis in cells expressing RTA and the 
dominant negative CDC48QQ was reduced by 
only 30%, a statistically significant difference 
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(P<0.05). That such rescue was a general 
consequence of expressing CDC48QQ was ruled 
out from controls that show a consistent 
inhibition of protein synthesis (by more than 80%) 
when ricin A chain was deliberately expressed in 
the cytosol without a signal peptide (cRTA), 
either in the presence or absence of wild type or 
mutant CDC48 (Fig. 3A). The significant rescue 
of protein synthesis shown in Fig. 3 therefore 
occurred only when RTA was initially targeted 
into the ER lumen in the presence of CDC48QQ. 
This would suggest that CDC48QQ mitigates the 
toxic effect of RTA by impeding its retro-
translocation to the cytosol. Since this experiment 
relies on efficient co-transfection, we checked the 
ability of protoplasts to take up multiple plasmids. 
Fig. 3B is a representative set of images showing 
that protoplasts competent to take up a YFP 
expressing plasmid in all cases concomitantly co-
express an RFP plasmid.  
 
To confirm toxin retro-translocation, we 
determined the location of the stabilized RTA. 
Cells expressing ER-targeted RTAE177D alone or 
together with either wild-type or mutant CDC48 
were pulsed with [35S]-labeled amino acids 
before being fractionated into membranes (M) 
and cytosol (C). As shown in Fig. 4A (lane 4), a 
significant amount of the RTAE177D synthesized 
was recovered in the cytosol fraction under these 
conditions. By contrast, virtually no toxin 
accumulated in the cytosol of cells expressing 
CDC48QQ (Fig. 4A, lane 8). BiP 
immunoprecipitates from the same samples 
indicate the integrity of the membrane fractions 
and show that the cytosolic RTA was unlikely to 
result from membrane leakage during cell lysis 
and membrane preparation. It is noticeable that 
the form accumulating in the cytosol was 
equivalent to the slowest migrating species 
observed in the membrane fractions. This higher 
RTA band is reminiscent of the mannose-
untrimmed species seen in previous pulse-chase 
experiments (18). Regardless of the precise 
glycan forms however, it is clear that co-
expression of mutant CDC48QQ impaired the 
retro-translocation of RTA to the cytosol.  
  
To investigate whether RTA was retained inside 
the membranes we carried out a protease 
protection experiment using cell extracts 
containing ER microsomes (25). Accordingly, at 
the 3 hour chase point, when RTA was largely 
sensitive to proteinase K under normal conditions 
(Fig. 4B, lane 5), a proportion of this protein was 
clearly protected from protease when made in the 
presence of CDC48QQ (Fig. 4B, lane 11, and 
quantified from three independent repeats in Fig. 
4C). Based on the statistical analysis, there is 
significantly more protease-protected RTA in the 
cells expressing CDC48QQ (Fig. 4C). The faster 
migrating species, visualized upon incubation of 
the samples with protease, most likely represents 
a membrane protected remnant of the fraction of 
RTA that was in the process of being retro-
translocated at the time of cell lysis and that may 
have been partially exposed to the cytosol. 
Consistent with this, we observed the complete 
disappearance of this fragment when the 
membranes were treated with protease 
concomitant with membrane solubilization (Fig. 
4B, lanes 3, 6, 9 and 12). 
 
Toxins can be retro-translocated in mannose-
trimmed and untrimmed forms, but only when 
CDC48 is active – We next used cells expressing 
either ER-targeted RTAE177D or a comparable 
inactive version of its relative, Ricinus communis 
agglutinin (RCA AE176D (33)), and analyzed the 
presence or absence of these orphan proteins in 
the cytosol and membrane fractions over time. It 
was noticeable that RTA, but not RCA A, 
underwent a slight shift in size during pulse-
chase experiments (Fig. 5, top panel). This slight 
downsizing of RTA can be blocked using the ER 
mannosidase inhibitor 1-deoxymannojirimycin 
(DMM) (Fig. 5, second panel) to generate a 
species that is now comparable with the sharper 
bands observed for RCA A. Clearly, the 
appearance of RTA in the cytosol does not 
critically depend on prior mannose trimming 
events. Taken together, these observations 
suggest that the core glycan of RCA A may not 
normally be a substrate for extensive 
mannosidase action, and that the retro-
translocation machinery does not differentiate 
between the different glycosylated forms 
presented by RTA and RCA A.  
 
As observed before for RTA (17,18), there is a 
qualitative loss of both toxin chains from 
membrane fractions with time (Fig. 5, top two 
panels). That this is due to retro-translocation and 
cytosolic degradation is indicated from 
experiments in which proteasome activity was 
compromised using clasto-lactacystin β-lactone 
(Fig 5, third panel). We have previously observed 
that this conventional inhibitor of mammalian 
proteasomes does not completely block RTA 
degradation. Nevertheless, under these conditions, 
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the cytosolic turnover of both toxin A chains was 
sufficiently hindered to permit the more rapid 
appearance of a faster migrating intermediate 
(Fig. 5, third panel, asterisk) that was absent in 
non transfected controls. This species of RTA 
was previously shown to be a deglycosylation 
product of cytosolic peptide N:glycanase that 
becomes more noticeable when proteasomes are 
partially inhibited (17). Strikingly, when DMM 
was used (to maintain both toxins as tight 
homogenous bands) together with the proteasome 
inhibitor and CDC48QQ, neither A chain was 
observed in cytosolic fractions (Fig. 5, compare 
cytosol fractions in the top three panels with 
panel four). The bottom panel reveals the 
distribution of ER BiP to indicate the integrity of 
the membrane fractions. Clearly, the effect of 
CDC48QQ was to severely compromise 
emergence of both Ricinus toxins into the cytosol.  
 
  
Cycling via the Golgi can preface retro-
translocation – RTA and RCA A, though very 
closely related, appear to be handled differently 
upon their synthesis in the plant cell. Both 
polypeptides become core-glycosylated at a 
single site (N10) upon entering the ER lumen, and 
such glycans can be removed by treatment with 
endoglycosidase H. Although we know that RTA, 
in the absence of its normal partner B chain, is 
neither secreted nor delivered to vacuoles in 
tobacco cells (21), a significant proportion of this 
newly made protein was found to be Endo H-
resistant (Fig. 6A, top panel, lanes 4-6). This 
supports a cycling of RTA from ER-to-Golgi-to-
ER, and an encounter with Golgi glycan-
modification enzymes. By contrast, RCA A does 
not acquire Endo H-resistance under identical 
conditions (Fig. 6A, lower panel, lanes 4-6) 
suggesting that cycling of these soluble proteins 
in the early secretory pathway is not obligatory 
for their retro-translocation. In the presence of 
CDC48QQ, a greater proportion of the total 
population of newly made RTA became Endo H 
resistant (Fig. 6A, top panel, compare lanes 4-6 
with lanes 10-12), presumably because cycling 
continues even when retro-translocation is 
perturbed. Indeed, when retro-translocation is 
inhibited, a proportion of RCA A also reveals 
Endo H resistance (Fig. 6A, lower panel, lanes 
11-12). The quantification of the proportion of 
Endo H-resistant species at the 5 h chase points 
from three independent experiments are shown in 
Fig. 6B. They reveal a statistically significant 
difference between the fraction of Endo H-
resistant RTA and RCA A chains, and also 
between RCA A made in the absence or presence 
of CDC48QQ. A possible rationalisation for the 
latter is that when retrotranslocation is 
compromised, RCA A has greater opportunity to 
be cycled via the Golgi and to acquire Endo H-
resistance. Note that both RTA and RCA A 
appear to be degraded at comparable rates during 
the chase when wild type CDC48 is present, 
indicating that retro-translocation is independent 
of glycan structure. This was confirmed for RTA 
where both the Endo H-sensitive and Endo H-
resistant forms were observed in the cytosolic 
fraction (Fig. 6C).  
 
CDC48-mediated retro-translocation of RTA 
does not require polyubiquitination of lysine 
residues – The CDC48/p97 complex is believed 
to function in retro-translocation by interacting 
with polyubiquitin chains on exposed client 
proteins and mechanically extracting them from 
the ER membrane. Studies in mammalian cells 
with the non-ubiquitinated but nevertheless still 
retro-translocated substrate cholera toxin A1 
chain (12) have shown that cytosolic p97 was not 
required. A similar situation may exist for RTA, 
since only the degradation of this protein rather 
than its retrotranslocation was affected by a 
modulation of lysine content (18). It is evident 
that a lysyl-free toxin variant (RTAE177D0K) is 
able to retro-translocate when endogenous or 
endogenous plus over-expressed wild type 
CDC48 are present (Fig. 7, lanes 7 to 12 and 13 
to 18, respectively). However, when the mutant 
ATPase is present, the dislocation of the lysine-
free toxin to the cytosol is completely prevented 
(Fig. 7, lanes 20, 22 and 24).  
 
DISCUSSION 
 
To test for a dominant negative effect of CDC48, 
we monitored the up-regulation of ER 
chaperones that follows the inhibition of retro-
translocation and that forms part of the unfolded 
protein response. Figure 1 reveals a significant 
induction of chaperones in cells expressing 
CDC48QQ, but not in cells that make the wild 
type protein, and confirms, in plant cells, an 
effect of the mutant ATPase that is well known in 
other systems (12,34,35). 
 
The process of ERAD typically begins with the 
recognition of a substrate as being misfolded or 
orphan. The structural features recognized are not 
known in most cases, but for newly made RTA 
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(and its close relative RCA A) it is likely that, in 
the absence of cognate B chain(s), exposed 
hydrophobic stretches of amino acids normally 
masked in the holotoxin (36) may trigger 
chaperone or lipid interactions (37) to prevent 
aggregation. Persistent absence of the partner B 
chain appears, however, to lead to a redirection 
of the catalytic A subunit to the retro-
translocation machinery (17), which is likely to 
be a protein-conducting channel in the ER 
membrane (38). Once exposed on the cytosolic 
face of the ER membrane, most ERAD substrates 
become oligoubiquitinated on lysyl residues in a 
process requiring specific membrane-associated 
ubiquitin conjugating enzymes and ligases (e.g. 
the Doa10p and Hrd1p complexes in yeast (39-
43)). This is usually followed by an ATP-
dependent extraction process, during which the 
ubiquitin-binding CDC48 (p97 in mammals) and 
its cofactors Ufd1p and Npl4p are recruited to the 
membrane by Ubx2 (44). The substrate is usually 
then polyubiquitinated by E3 enzymes such as 
Ufd2 (45) or the N-glycan-specific SCFFbs1 and 
SCFFbs2 complexes (46,47),  followed by 
deglycosylation where appropriate (48), and 
passage on to proteasomes for destruction. 
 
In comparison to the extensive characterization 
of mammalian and yeast ERAD, the molecular 
and mechanistic details of this process in plant 
cells remains very poorly understood. Earlier 
identification of plant ERAD substrates, either 
misfolded (16,49) or orphan as here (17,18), now 
opens the way to identifying the key players and 
requirements in this system. It should be noted 
that the behaviour of newly synthesized ricin A 
chain in the ER of plant cells reflects, in outline 
at least, the situation observed when disulfide 
bonded A-B ricin holotoxin is endocytosed into 
the mammalian ER, whereupon reduction sparks 
the retro-translocation of the catalytic subunit. In 
both scenarios (biosynthesis of RTA in the plant 
cell or its liberation in the ER of mammalian cells 
following holotoxin endocytosis and reduction), 
most retro-translocated RTA appears to be locked 
in a tightly coupled pathway leading to 
proteasomal degradation (50). However, a 
fraction of RTA is known to uncouple from this 
pathway, and to refold and intoxicate either the 
ultra-sensitive mammalian ribosomes or the more 
recalcitrant plant ribosomes (51). Such 
degradation avoidance is known to be linked to 
the scarcity of lysyl residues in the toxin moiety 
that prevents this protein becoming efficiently 
ubiquitinated (52).  
 
The observation that most retro-translocated 
substrates are ubiquitinated and pulled from the 
ER membrane by virtue of this modification begs 
the question, what happens to proteins that are 
not ubiquitinated (10-12)? It has been shown for 
non-ubiquitinated pre-pro α-factor that ATPases 
in the 19S proteasome regulatory complex can 
provide an alternative driving force (10,53) for 
membrane extraction. It is also evident from 
functional analyses that p97 is not required for 
the retro-translocation of ubiquitin-free cholera 
toxin A1 chain in mammalian cells (12). The 
driving force in this latter case is not known with 
certainty. Such findings have led to the 
suggestion that the p97 (CDC48)-Ufd1-Npl4 
complex may operate only for substrates that are 
modified by ubiquitin (12). However, it is clear 
that there are other instances where CDC48 is 
known to be dispensable (54) or to play a more 
ancillary than obligatory role (55). Here, we have 
shown that CDC48 does participate in the retro-
translocation of the orphan toxin subunits (RTA 
and RCA A; Fig. 5), even when completely 
lacking in lysine residues (as with RTA 0K; Fig. 
7). Assuming that atypical N-terminal 
ubiquitination is not occurring in this instance, 
this finding would suggest that the ATPase can 
facilitate the extraction of a non-ubiquitinated 
protein. It remains to be seen whether or not the 
requirement for CDC48 involves direct 
interaction with the toxin polypeptides.  
 
In the presence of CDC48QQ, glycosylated RTA 
is partially stabilized (Fig. 2), is considerably less 
toxic to ribosomes (Fig. 3), and is localized to the 
membrane fraction (Fig. 4). Likewise, RCA A is 
similarly stabilised and retained in a membrane 
fraction when CDC48 function is impaired (Fig. 
5). That CDC48QQ was responsible for these 
effects rather than the UPR itself is shown in 
Figure 2. From this, it is clear that induction of 
the UPR by a different means (blocking 
glycosylation by treatment of cells with 
tunicamycin, thus increasing the levels of 
misfolded proteins) does not result in a 
stabilization of RTA.   
 
It is also noticeable that the two toxin subunits 
are processed differently in preparation for 
dislocation. In the case of RTA, its emergence 
into the cytosol appears to involve two species – 
an initial mannose-untrimmed version and, at 
later chase points, a mannose-trimmed version 
(Fig. 5, top panel). The mannose-trimmed version 
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appearing at later chase times may well represent 
the fraction of RTA that has undergone cycling 
via the Golgi (Fig. 6A), since only at such a time 
point is an Endo H resistant form present in the 
cytosol fraction (Fig. 6C). This species would 
need to have undergone mannose trimming and 
anterograde export from the ER to reach the 
enzymes that render the toxin glycan resistant to 
Endo H. By contrast, RCA A is not mannose-
trimmed or cycled via the Golgi (Figs. 5 and 6). 
Despite these differences, both polypeptides are 
retro-translocated with similar kinetics in a 
CDC48-dependent manner. The reason for such a 
striking difference between two proteins that are 
94% identical at the primary sequence level and 
that possess an identical glycosylation site is not 
clear. It may be connected with the fact that RCA 
A, unlike RTA, is normally required to assemble 
into an A2-B2 tetramer in which disulfide bonds 
exist between each A and B chain and between 
the two A chains. This additional burden may 
lead to prolonged interactions and scrutiny by ER 
resident oxidoreductases that prevent the entry of 
this protein into an ER-to-Golgi cycling pathway. 
The cycling observed with RTA is reminiscent of 
some soluble substrates in yeast that rely on 
transport to the ER from the Golgi (56-58). 
 
It is evident from the limited number of studies 
that have been carried out that an ERAD-like 
protein disposal pathway does indeed operate in 
plant cells. However, the present dearth of known 
substrates means that many details and variations 
are yet to emerge, not least the range of cytosolic 
proteins dedicated to the extraction, modification 
and targeting of ER-sequestered substrates to the 
plant proteasome, and possibly to other cytosolic 
proteases. The finding that a CDC48 complex is 
required for the natural plant substrates described 
to date (16) suggests it is likely that the plant 
homologues of other mammalian and yeast 
ERAD components, found in Arabidopsis (59) 
and in other plants (60), may well have a 
functional role in this disposal pathway. In 
Arabidopsis, over 1300 genes (5% of the 
proteome) are devoted to the selective breakdown 
of proteins by the extensive ubiquitin/26S 
proteasome pathway (61), although virtually 
nothing at present is known about these 
components in relation to ERAD. It should also 
be noted that since plant cells have other 
proteolytic repositories, in the form of lytic 
vacuoles (62), where proteins can be degraded 
(63,64), the impact of this ERAD pathway to 
overall protein degradation, including the 
turnover of conformationally regulated proteins 
that may have critical roles in 
photomorphogenesis, pathogen defense, and 
hormonal regulation in the plant cell, remains to 
be determined.  
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FIGURE LEGENDS 
Figure 1.  Expression of CDC48QQ promotes an up-regulation of ER chaperones. A: 
Tobacco leaf cells were transfected, by Agrobacterium-mediated stomatal infiltration, with 
the pGreenII-0029 vector alone (vector) or with plasmids encoding wtCDC48 or CDC48QQ. 
After 3 days, protoplasts were recovered and pulsed with radioactive amino acids for 1 hour. 
Proteins were immunoselected sequentially from cell homogenates using anti-calreticulin, 
anti-GRP94 and anti-BiP antisera and analyzed by reducing SDS-PAGE and fluorography. 
BiP immunoprecipitates were exposed to film for 2 days while the GRP94 and calreticulin 
immunopreciptates were exposed for 10 days. Numbers on the left indicate molecular mass 
markers in kilodaltons. B: Quantitation of A, showing the average values from three 
independent experiments. The intensity of the immunoselected bands was measured by 
densitometry and expressed as a percentage of the control (vector). Bars indicate standard 
deviation and the presence of different letters above the bars indicate a significant difference 
(P<0.05).  
 
Figure 2. Expression of mutant CDC48 increases the stability of ER-sequestered ricin A 
chain. A: Protoplasts were transfected with pDHA vector alone (vector) or co-transfected 
with plasmids encoding ER-targeted ricin A chain with an active site mutation (RTAE177D), 
and either wtCDC48 or CDC48QQ. Where indicated, protoplasts were pre-incubated for 1 
hour with 50µg/ml tunicamycin. Protoplasts were radiolabeled with [35S]-amino acids for 1 
hour and chased with unlabeled amino acids for the times indicated. RTA was 
immunoprecipitated from cell homogenates and analyzed by reducing SDS-PAGE and 
fluorography. The single asterisk indicates the position of glycosylated RTA while the double 
asterisk marks the position of non-glycosylated RTA. The position of the 30 kDa molecular 
mass marker is indicated on the left. B: Quantitation of the amount of immunoprecipitated 
RTA, made in the presence of wtCDC48, CDC48QQ or tunicamycin, as measured by 
densitometry and expressed as a percentage of the total RTA present at the end of the pulse. 
The graph shows the average values from four independent experiments. Bars indicate 
  
 
13
standard deviation and different letters at the end of each series indicate a significant 
difference (P<0.05) between treatments at all but the zero time point. 
 
Figure 3. Expression of a mutant CDC48 decreases the toxicity of RTA to ribosomes. A: 
Triplicate preparations of protoplasts were co-transfected with a plasmid encoding a phaseolin 
protein synthesis reporter along with either pDHA vector alone (no toxin) or a plasmid 
encoding ER-targeted RTA (RTA) or cytosolic RTA (cRTA). These co-transfections were 
carried out in combination with either the pamPAT-MCS vector alone (no CDC48), or this 
plasmid encoding either wtCDC48 or CDC48QQ. Protoplasts were pulsed for 1 hour before 
cell lysis, and immunoprecipitates were subjected to SDS-PAGE, as described for Figure 2. 
Fluorographs of a representative set of phaseolin immunoprecipitates taken from one of three 
experimental repeats are shown above the relevant densitometry quantifications. The levels of 
phaseolin made in the absence of any toxin expression are taken as 100%. The other data are 
expressed as a percentage of this and represent the average values from three independent 
experiments. Bars indicate standard deviation and different letters above bars indicate a 
significant difference (P<0.05). B: Protoplasts were co-transfected with plasmids encoding 
cytosolic YFP and cytosolic RFP. After overnight expression cells were analyzed by confocal 
microscopy. Panels A and E show YFP fluorescence (green), panels B and F show RFP 
fluorescence (red), and panels C and G show merged images. Panels D and H represent the 
total cell population. YFP was excited at 514nm, and RFP was excited at 561nm. All images 
shown were acquired using the same photomultiplier gain and offset settings. For each sample, 
two magnifications are shown. Scales bars represent 50µm (panels A-D) and 400µm (panels 
E-H). 
 
Figure 4. RTA is retained in the membrane fraction when CDC48-dependent retro-
translocation is impaired. A: Protoplasts were transfected with pDHA vector alone (vector) 
or the RTAE177D-encoding plasmid plus wtCDC48 or CDC48QQ plasmids. Protoplasts were 
radiolabeled with [35S]-cysteine and [35S]-methionine for 6 hours, before being homogenized 
in the absence of detergent and fractionated to yield microsomes (M) and cytosol (C). 
Proteins were immunoselected sequentially using anti-RTA and anti-BiP antisera, and 
analyzed by reducing SDS-PAGE and fluorography. Numbers on the left indicate molecular 
mass markers in kilodaltons.  B: Protoplasts were transfected with the plasmids shown, before 
being radiolabeled for 1 hour and chased as indicated. The cells were then homogenized as in 
A, before dividing three ways and incubating in the absence or presence of proteinase K (PK) 
and detergent (Triton X-100). RTA was immunoselected and resolved as in A. The position 
of the 30 kDa molecular mass marker is indicated on the left. C: Quantitation, from 3 separate 
pulse-chase experiments, of the amount of RTA made in the absence or presence of 
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CDC48QQ that was subsequently protected from proteinase K after 3 hours. Bars indicate 
standard deviation and different letters above bars indicate a significant difference (P<0.05). 
 
Figure 5. CDC48-dependent retro-translocation does not distinguish between different 
glycosylated forms. Protoplasts were transfected with pDHA vector alone (control), or 
constructs encoding ER-targeted RTAE177D or Ricinus communis agglutinin A chain with the 
equivalent active site point mutation (RCA AE176D). Where indicated, protoplasts were co-
transfected with a plasmid expressing CDC48QQ, pre-incubated for 1 hour with 5mM 1-
deoxymannojirimycin (DMM) before radiolabeling, and/or incubated with 80µM clasto-
lactacystin β-lactone during the pulse. Protoplasts were subjected to pulse-chase before being 
homogenized in the absence of detergent. Homogenates were centrifuged to yield microsomal 
(M) and cytosol (C) fractions and proteins immunoprecipitated sequentially using anti-RTA 
and anti-BiP antisera before analysis by reducing SDS-PAGE and fluorography. A 
representative gel showing the distribution of BiP in the membrane and cytosol fractions is 
shown in the bottom panel. The asterisk at the right hand side of the β-lactone panel indicates 
the likely deglycosylated RTA species that is more clearly observed when proteasomes are 
inhibited (17). Numbers on the left indicate molecular mass markers in kilodaltons. 
 
Figure 6. A plant ERAD substrate may cycle through the Golgi prior to its CDC48-
dependent retro-translocation. A: Protoplasts were co-transfected with plasmids encoding 
RTAE177D or RCA AE176D, and wtCDC48 or CDC48QQ, before pulse-chase analysis. RTA or 
RCA A were immunoprecipitated, and the immunoprecipitates treated for 16 hours in the 
absence or presence of endoglycosidase H (Endo H) before analysis by reducing SDS-PAGE 
and fluorography. The position of the 30 kDa molecular mass marker is indicated on the left. 
B: Quantitation, from 3 separate pulse-chase experiments, of the amounts of RTA or RCA A, 
made in the absence or presence of CDC48QQ, that were resistant to Endo H treatment after 5 
hours. Bars indicate standard deviation and different letters above bars indicate a significant 
difference (P<0.05). C: Protoplasts were transfected to express RTAE177D, radiolabeled as in 
A, and chased with unlabeled amino acids for 0 and 2.5 hours, before being homogenized in 
the absence of detergent. Homogenates were fractionated into microsomes (M) and cytosol (C) 
and RTA immunoselected, treated with Endo H and analyzed as in A. The position of the 30 
kDa molecular mass marker is indicated on the left. 
 
Figure 7. CDC48-dependent retro-translocation can be independent of lysyl 
ubiquitination. Protoplasts were transfected with pDHA vector alone (vector) or with a 
plasmid encoding RTAE177D lacking its two endogenous lysine residues (RTAE177D 0K), plus a 
wtCDC48 or CDC48QQ construct where indicated. Protoplasts were subjected to a 1 hour 
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pulse and chased as shown. Cell homogenates were centrifuged to yield microsomal (M) and 
cytosol (C) fractions, and proteins immunoselected sequentially using anti-RTA and anti-BiP 
antisera before analysis by reducing SDS-PAGE and fluorography. Numbers on the left 
indicate molecular mass markers in kilodaltons. 
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